Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation.

Laurence Faivre 1, 2, * Gwenaëlle Collod-Beroud 3 Bert Callewaert 4 Anne Child 5 Christine Binquet 1 Elodie Gautier 1 Bart Loeys 4, 6 Eloisa Arbustini 7 Karin Mayer 8 Mine Arslan-Kirchner 9 Chantal Stheneur 10 Anatoli Kiotsekoglou 5 Paolo Comeglio 5 Nicola Marziliano 7 Jean-Eric Wolf 11, 12 Olivier Bouchot 13 Philippe Khau-Van-Kien 3 Christophe Béroud 3 Mireille Claustres 3 Claire Bonithon-Kopp 1 Peter Robinson 14 Lesley Adès 15, 16, 17 Julie De Backer 4 Paul Coucke 4 Uta Francke 18 Anne De Paepe 4 Guillaume Jondeau 19 Catherine Boileau 20, 21, 22
Abstract : Mutations in the FBN1 gene cause Marfan syndrome (MFS) and a wide range of overlapping phenotypes. The severe end of the spectrum is represented by neonatal MFS, the vast majority of probands carrying a mutation within exons 24-32. We previously showed that a mutation in exons 24-32 is predictive of a severe cardiovascular phenotype even in non-neonatal cases, and that mutations leading to premature truncation codons are under-represented in this region. To describe patients carrying a mutation in this so-called 'neonatal' region, we studied the clinical and molecular characteristics of 198 probands with a mutation in exons 24-32 from a series of 1013 probands with a FBN1 mutation (20%). When comparing patients with mutations leading to a premature termination codon (PTC) within exons 24-32 to patients with an in-frame mutation within the same region, a significantly higher probability of developing ectopia lentis and mitral insufficiency were found in the second group. Patients with a PTC within exons 24-32 rarely displayed a neonatal or severe MFS presentation. We also found a higher probability of neonatal presentations associated with exon 25 mutations, as well as a higher probability of cardiovascular manifestations. A high phenotypic heterogeneity could be described for recurrent mutations, ranging from neonatal to classical MFS phenotype. In conclusion, even if the exons 24-32 location appears as a major cause of the severity of the phenotype in patients with a mutation in this region, other factors such as the type of mutation or modifier genes might also be relevant.
Type de document :
Article dans une revue
European Journal of Human Genetics, Nature Publishing Group, 2009, 17 (4), pp.491-501. 〈10.1038/ejhg.2008.207〉
Liste complète des métadonnées

Littérature citée [52 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00343925
Contributeur : Gwenaëlle Collod-Beroud <>
Soumis le : mercredi 20 décembre 2017 - 18:03:12
Dernière modification le : mercredi 25 juillet 2018 - 01:24:39

Fichier

2009-EJHG ...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Laurence Faivre, Gwenaëlle Collod-Beroud, Bert Callewaert, Anne Child, Christine Binquet, et al.. Clinical and mutation-type analysis from an international series of 198 probands with a pathogenic FBN1 exons 24-32 mutation.. European Journal of Human Genetics, Nature Publishing Group, 2009, 17 (4), pp.491-501. 〈10.1038/ejhg.2008.207〉. 〈inserm-00343925v2〉

Partager

Métriques

Consultations de la notice

354

Téléchargements de fichiers

115